This time we are looking on the crossword clue for: Rx watchdog.
it’s A 11 letters crossword puzzle definition. See the possibilities below.
Did you find what you needed?
We hope you did!. If you are still unsure with some definitions, don’t hesitate to search them here with our crossword solver.
Possible Answers: FDA.
Last seen on: –LA Times Crossword, Fri, Nov 17, 2023
–Universal Crossword – Mar 20 2019
–NY Times Crossword 19 Dec 18, Wednesday
Random information on the term “FDA”:
Scott Gottlieb is an American physician who serves as commissioner of the Food & Drug Administration. He is a clinical assistant professor at New York University School of Medicine, a resident fellow at the conservative think tank the American Enterprise Institute, and an internist at Tisch Hospital.
Gottlieb grew up in East Brunswick, New Jersey, the son of Stanley, who is a psychiatrist, and Marsha Gottlieb. He received his bachelor’s degree in economics from Wesleyan University. After completing his undergraduate education, he worked as a healthcare analyst at the investment bank Alex. Brown & Sons in Baltimore. Gottlieb attended medical school at Mount Sinai School of Medicine and completed his residency in internal medicine at the Mount Sinai Hospital.
Gottlieb has worked in multiple roles for the federal government of the United States, including as Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration (FDA), in which capacity he served from 2005 to 2007. He helped initiate the early development of the FDA’s generic drug user fee program and the agency’s release of the Physician Labeling Rule. He also worked on development of the FDA’s policies related to the tentative approval of fixed dose combination drugs for the treatment of HIV/AIDS under the PEPFAR program. He was appointed to the Senior Executive Service and granted a top secret security clearance during his appointment as the FDA’s Deputy Commissioner for Medical and Scientific Affairs. He was also as a member of the White House Biodefense Interagency Working Group, which was convened after the September 11 attacks to help draft a strategic plan for the development of U.S. biodefense countermeasures. While working for the FDA, Gottlieb had to recuse himself from working on planning for a possible bird flu because he had done consulting work for companies whose products may be used to combat the bird flu. Before becoming the FDA’s Deputy Commissioner, Gottlieb served as a senior advisor to the FDA Commissioner and as the FDA’s Director of Medical Policy Development.